"Breakthrough Clinical Trial Brings New Hope for Managing Uncontrolled Hypertension"

Hypertension, or high blood pressure, poses serious health risks. The Advance-HTN trial evaluated lorundrostat, a novel treatment for uncontrolled hypertension. Involving 285 participants, results showed significant blood pressure reductions. While promising, safety concerns like hyperkalemia were noted, suggesting careful monitoring is essential for those considering this new option.